ORTX News and Press, Orchard Therapeutics plc From 11/13/23

Orchard Therapeutics plc (ORTX) is expected to report $-1.3 for Q3 2023

NEW YORK, NY / ACCESSWIRE / October 28, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Mirati Therapeutics, Inc. (NASD...

BOSTON and LONDON, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced a range of interim clinical outcomes, in addition to the previously reported neurological and skeletal results, from the company’s ongoing proof-of-concep...

Eight presentations highlight the differentiated profile and broad applicability of the company’s HSC gene therapy platform Data from proof-of-concept study of OTL-203 in MPS-IH demonstrate favorable outcomes for clinical manifestations of the disease not well addressed by the cu...

NEW YORK, NY / ACCESSWIRE / October 9, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: SP® Plus Corporation (NASDA...

2023-10-05 12:59:42 ET More on Grupo Aeroportuario del Centro Norte, Grupo Aeroportuario del Pacifico, etc. For further details see: BTWN, OMAB and PAC among mid-day movers

2023-10-05 11:37:13 ET Shares of the commercial-stage gene therapy company Orchard Therapeutics (NASDAQ: ORTX) were up by a noteworthy 98% on sky-high volume as of 10:13 a.m. ET Thursday morning. The biotech's stock is rocketing higher on the news that the Japanese biopharma Kyowa...

2023-10-05 10:38:59 ET Shares of Orchard Therapeutics (NASDAQ: ORTX) almost doubled this morning after Kyowa Kirin Co Ltd (TYO: 4151) announced plans of buying the gene therapy company. Details of Orchard-Kyowa definitive agreement The Japanese specialty pharmaceutical firm is w...

2023-10-05 10:00:20 ET More on Health Care Select Sector SPDR BofA Securities: Which small cap non-earner stocks to avoid Citi turns cautious on pharmaceuticals and biotech For further details see: Orchard Therapeutics, Longeveron among healthcare movers

Shares of Orchard Therapeutics PLC (NASDAQ: ORTX) traded at a new 52-week high today and are currently trading at $15.94. So far today, approximately 5.04M shares have been exchanged, as compared to an average 30-day volume of 101.26k shares. Orchard Therapeutics PLC, a biopharmaceutical comp...